Armata Pharmaceuticals, Inc. (ARMP)
NYSE American · Manufacturing · Biological products, (no diagnostic substances)
ARMP price, last 12 months
Key stats
- Previous close
- $3.62
- Open
- $3.60
- Day range
- $3.56 – $3.81
- 52-week range
- $2.94 – $16.34
- Volume
- 100.8K
- Avg volume (20 days)
- 369.9K
- Market cap
- $139.1M
Performance
Technicals and fundamentals
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NYSE American
- Market cap
- $139.1M